Cargando…
Anti-DFS70 Antibodies for Differentiating Systemic Autoimmune Rheumatic Disease in Patients with Positive ANA Tests: A Systematic Review and Meta-Analysis
Anti-DFS70 antibodies have been proposed as a marker to exclude systemic autoimmune rheumatic disease (SARD). We conducted this systematic diagnostic test accuracy review and meta-analysis to determine the performance of anti-DFS70 antibodies in patients with a positive anti-nuclear antibody (ANA) t...
Autores principales: | Cheng, Chiao-Feng, Shih, Ming-Chieh, Lan, Ting-Yuan, Li, Ko-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468616/ https://www.ncbi.nlm.nih.gov/pubmed/34573934 http://dx.doi.org/10.3390/diagnostics11091592 |
Ejemplares similares
-
Measurement of anti-DFS70 antibodies in patients with ANA-associated autoimmune rheumatic diseases suspicion is cost-effective
por: Gundín, Simón, et al.
Publicado: (2016) -
Low Prevalence of Anti-DFS70 Antibodies in Children With ANA-Associated Autoimmune Disease
por: Freudenhammer, Mirjam, et al.
Publicado: (2022) -
Clinical Phenotypes of Patients with Anti-DFS70/LEDGF Antibodies in a Routine ANA Referral Cohort
por: Miyara, Makoto, et al.
Publicado: (2013) -
Prevalence and serological profile of anti-DFS70 positive subjects from a routine ANA cohort
por: Carbone, Teresa, et al.
Publicado: (2019) -
Analysis of DFS70 pattern and impact on ANA screening using a novel HEp-2 ELITE/DFS70 knockout substrate
por: Malyavantham, Kishore, et al.
Publicado: (2017)